Keywords: alkermes, narrows, net, loss, 2nd, qtr, usa-based

Alkermes narrows net loss for 2nd qtr

Article | 15 November 2004

USA-based Alkermes sliced its net loss 45% to $14.3 million, or $0.16 a share, for the second quarter of fiscal 2005, ended September 30, 2004, on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Risperidone

Risperdal

Risperdal Consta

Humulin 70-30

Insulin

Go to drug listing